A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia patients with randomization

Leukemia Research

Volumn 22, Issue 6, 1998, Pages 485-493

  Yetgin, Sevgi ^a   Gürgey, Aytemiz ^a   Murat Tuncer, A ^a   Çetin, Mualla ^a   Özbek, Namik ^a   Şayli, Tülin ^a   Güler, Ertugrul ^a   Kara, Abdurrahman ^a   Olcay, Lale ^a   Duru, Feride ^a   Gümrük, Fatma ^a   Atahan, Lale ^a   Tunçbilek, Ergul ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Event free survival; High risk; High dose methylprednisolone; Induction chemotherapy

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERTENSION; INFANT; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SURVIVAL RATE;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT; INFECTION; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTE COUNT; MALE; METHYLPREDNISOLONE; NEUTROPENIA; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 17144460488     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00003-4     Document Type: Article

References (37)

1. Goldie J.H., Coldman A.J., Gudauskas G.A. Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep. 66:1982;439.
2. Clavell L.A., Gelber R.D., Cohen H.J., Hitchcock-Bryan S., Cassady I.R., Tarbel N.J., Blattner S.R., Tantravahi R., Leavitt P., Sallan S.E. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. New Engl J Med. 315:1986;657.
3. Riehm H., Gadner G., Henze G., Kornhuber B., Lampert F., Neithammer D., Reiter A., Schellong G. Results and significance of six randomized trials in four consecutive ALL-BFM studies. Hamatol Bluttransfus. 33:1990;439.
4. 9/l. Clin Oncol. 5:1987;1015.
5. Rivera G.K., Raimondi S.C., Hancock M.L., Behm F.G., Pui C.-H., Abromowitch M., Mirro J., Ochs J.S., Look A.T., Williams D.L., Murphy S.B., Dahl G.V., Kalwinsky D.K., Evans W.E., Kun L.E., Simone J.V., Crist W.M. Improved outcome in childhood acute lymphoblastic leukeamia with reinforced early treatment and rotational combination chemotherapy. Lancet. 339:1991;61.
6. Pui C.H., Simone J.V., Hancock M.L., Evans W.E., Williams D.L., Bowman W.P., Dahl G.V., Dodge R.K., Ochs J., Abromowitch M., Rivera G.K. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long term results of St Jude Total Therapy Study X. Leukemia. 6:1992;150.
7. Rivera G.K., Pinkel D., Simone J.V., Hancock M.L., Crist W.M. Treatment of acute lymphoblastic leukemia. 30 years experience at St. Jude Children's Research Hospital. New Engl J Med. 329:1993;1289.
8. Bernard J., Deltour G. Les nouveaux traitements des leucoses; T.E.P.A.-G.T. 41-6-mercaptopurine-β-mercaptoethanolamine: doses tres fortes de cortisone. Sem Hop. 27:1953;3430.
9. Hill J.M., Marshall G.J., Falco D.J. Massive prednisone and prednisolone therapy in leukemia and lymphomas in the adult. J Am Geriatr Soc. 4:1956;627.
10. Ranney H., Gelhorn A. The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphoma. Am J Med. 22:1957;405.
11. Shambron E., Miller S. Critical evaluation of massive steroid therapy of acute leukemia. New Engl J Med. 266:1962;1354.
12. Hiçsönmez G., Özsoylu Ş., Gürgey A., Zamani V.P., Irken G. High-dose methylprednisolone for remission induction in children with acute nonlymphoblastic leukemia. Eur J Haematol. 42:1989;498.
13. Hiçsönmez G., Özsoylu Ş., Tuncer M.A. Differentiation of myeloid leukemic cells induced by high dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential. Leuk Res. 15:1991;537.
14. Hiçsönmez G., Özsoylu Ş., Tuncer M.A., Ertürk G., Özbek N., Karadeniz N. Direct morphological evidence of high-dose methylprednisolone induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia. Exp Hematol. 19:1991;232.
15. Hiçsönmez G., Karadeniz N., Prozorova Zamani V., Özsoylu Ş. High remission rate in acute myeloblastic leukemia in children treated with high-dose methylprednisolone. Eur J Haematol. 48:1992;215.
16. Özsoylu Ş. High dose intravenous methylprednisolone in hematologic disorders. Hematol Rev. 4:1990;197.
17. Motoji T., Teramura M., Takahassi M., Oshimi K., Okada M., Kusakabe K., Mizoguchi H. Successfull treatment of refractory anemia with high-dose methylprednisolone. Am J Hematol. 33:1990;8.
18. Ryalls M.R., Pinkerton C.R., Meller St., Talbot D., McElwain T.C. High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 20:1992;119.
19. Hiçsönmez G., Özsoylu Ş., Onat N., Zamani Vahide P., Gumruk F., Tuncer M. High dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia. Med Pediatr Oncol. 22:1994;68.
20. Hiçsönmez G., Gümrük F., Zamani V.P., Tuncer A.M., Yetgin S., Gürgey A., Atahan L., Özsoylu Ş. High-dose methylprednisolone in the treatment of children with high risk lymphoblastic leukemia. Eur J Hematol. 58:1997;26.
21. Spurbeck J.L., Carlson R.D., Allen J.E., Dewald G.W. Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. Cancer Genet Cytogenet. 32:1988;59.
22. Mitelman F. An International System for Human Genetic Nomenclature. Basel: Karger, 1995.
23. Metcalf D. Cortisone action on serum colony stimulating factor and bone marrow in vitro colony formation cells. Proc Soc Exp Biol Med. 132:1969;391.
24. Eliason J.F. Granulocyte-macrophage colony formation in serum free culture: effect of purified colony stimulating factors and modulation by hydrocortisone. J Cell Physiol. 188:1986;231.
25. Tuncer M., Hiçsönmez G., Ertürk G., Gümrük F., Albayrak D., Oguz H. The effect of high-dose methylprednisolone treatment on GM-CSF level in children with acute leukemia: a pilot study. Leuk Res. 16:1992;615.
26. Hiçsönmez G., Onat N., Albayrak D., Yetgin S., Özsoylu Ş. Acceleration of leukocyte recovery by administration of short course high-dose methylprednisolone in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 8:1991;193.
27. Çetin M., Hiçsönmez G., Tuncer A.M., Kansu E., Canpinar H. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia. Exp Hematol. 24:1996;1191.
28. Thomson EB, Harmon JM, Zawdiwski R. Corticosteroid effect on an acute lymphoblastic leukemia cell line: a model for understanding steroid therapy. In: Murphy SB, Jilbert JB, editors. Leukemia Research: Advances in Cell Biology and Treatment. New York: Elsevier, 1983:157.
29. Thomson E.B., Smith J.R., Bourgeois S., Harmon J.M. Glucocorticoid receptors in human leukemias and related disease. Clin Wochenschr. 63:1985;689.
30. Costlow M.E., Pui C., Dahl G.V. Glucocorticoid receptors in childhood acute lymphoblastic leukemia. Cancer Res. 42:1982;4801.
31. Yarbro G.S., Lippman M.E., Johnson G.E., Leventhal B.G. Glucocorticoid receptors in subpopulation of childhood acute lymphoblastic leukemia. Cancer Res. 37:1977;2688.
32. Schuler D., Szende B., Borsi J.D., Marton T., Bocsi J., Magyarossy E., Koss R., Csoka M. Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 11:1994;641.
33. Hiçsönmez G., Özsoylu Ş., Yetgin S., Zamani V., Gürgey A., Atahan L. Prognosis in 262 Turkish children with acute lymphoblastic leukemia. Turk J Pediatr. 24:1982;159.
34. Walters T.R., Bushore M., Simone J. Poor prognosis in negro children with acute lymphoblastic leukemia. Cancer. 29:1972;210.
35. Hiçsönmez G., Özsoylu Ş., Yetgin S., Zamani V., Gürgey A. Poor prognosis of childhood acute lymphoblastic leukemia. Br Med J. 286:1983;1437.
36. Pui G.H., Behm F.G., Raimondi S.C., Dodge R.K., George S.L., Rivera G.K., Mirro J., Kalwinsky D.K., Dahl G.V., Murphy S.B., Crist W.M., Williams D.L. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. New Engl J Med. 321:1989;136.
37. Çetin M., Yetgin S., Kara A., Tuncer M., Gunay M., Gümrük F., Gürgey A. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia. J Med. 25:1994;219.